» Articles » PMID: 16339512

Cutting Edge: Lectin-like Transcript 1 is a Ligand for the CD161 Receptor

Overview
Journal J Immunol
Date 2005 Dec 13
PMID 16339512
Citations 141
Authors
Affiliations
Soon will be listed here.
Abstract

Human NK cells and subsets of T cells or NKT cells express the orphan C-type lectin receptor CD161 (NKR-P1A) of unknown function. In contrast to rodents that possess several NKR-P1 genes coding for either activating or inhibitory receptors, the nature of signals delivered by the single human NKR-P1A receptor is still to be clarified. In this article, we show that the lectin-like transcript 1 (LLT1) molecule is a ligand for the CD161 receptor. Engagement of CD161 on NK cells with LLT1 expressed on target cells inhibited NK cell-mediated cytotoxicity and IFN-gamma secretion. Conversely, LLT1/CD161 interaction in the presence of a TCR signal enhanced IFN-gamma production by T cells. These findings identify a novel ligand/receptor pair that differentially regulate NK and T cell functions.

Citing Articles

LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells.

Zhu S, Zuo S, Li C, You X, Jiang E, Feng X J Exp Clin Cancer Res. 2025; 44(1):25.

PMID: 39856752 PMC: 11763111. DOI: 10.1186/s13046-025-03273-2.


Recognition of Self and Viral Ligands by NK Cell Receptors.

Mariuzza R, Singh P, Karade S, Shahid S, Sharma V Immunol Rev. 2025; 329(1):e13435.

PMID: 39748148 PMC: 11695704. DOI: 10.1111/imr.13435.


Loss Promotes Chronic Hepatic Inflammation and Metabolic Dysregulation.

Yang S, Luo T, Liu H, Chen L, Wang J, Zhao Y Genes (Basel). 2024; 15(11).

PMID: 39596644 PMC: 11594155. DOI: 10.3390/genes15111444.


Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme.

Cooksey L, Friesen D, Mangan E, Mathew P Cells. 2024; 13(18.

PMID: 39329751 PMC: 11429815. DOI: 10.3390/cells13181567.


expression is associated with lung adenocarcinoma prognosis and immune infiltration and regulates lung adenocarcinoma cell proliferation and metastasis through the MAPK/ERK pathway.

Xu S, Xu Y, Chai W, Liu X, Li J, Sun L J Thorac Dis. 2024; 16(6):3764-3781.

PMID: 38983163 PMC: 11228747. DOI: 10.21037/jtd-24-8.